阿扑吗啡在帕金森病中的临床应用。
The clinical use of apomorphine in Parkinson's disease.
作者信息
Steiger M J, Quinn N P, Marsden C D
机构信息
Department of Clinical Neurology, Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
出版信息
J Neurol. 1992 Aug;239(7):389-93. doi: 10.1007/BF00812157.
PMID:1403022
Abstract
Our 2-year experience in the therapeutic use of subcutaneous apomorphine has involved 25 patients with Parkinson's disease, 10 of whom continue to use it chronically. On the basis of this experience, we have formulated certain indications for its use, together with suggested approaches to modify patients' oral drug regimes so that apomorphine can best be deployed to improve their quality of life.
摘要
我们在皮下注射阿扑吗啡治疗方面的两年经验涉及25例帕金森病患者，其中10例继续长期使用。基于这一经验，我们制定了其使用的特定适应症，以及修改患者口服药物方案的建议方法，以便能最好地利用阿扑吗啡改善他们的生活质量。
Zotero 插件